Medite Cancer Diagnostics, Inc. (MDIT)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 9, 2026
Medite Cancer Diagnostics Revenue
Medite Cancer Diagnostics had revenue of $2.39M in the quarter ending September 30, 2018, with 41.99% growth. This brings the company's revenue in the last twelve months to $8.13M, up 19.50% year-over-year. In the year 2017, Medite Cancer Diagnostics had annual revenue of $6.81M, down -26.25%.
Revenue (ttm)
8.13M
Revenue Growth
+19.50%
P/S Ratio
0.00
Revenue / Employee
117.87K
Employees
69
Market Cap
8.58K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2017 | 6.81M | -2.43M | -26.25% |
| Dec 31, 2016 | 9.24M | -649.00K | -6.56% |
| Dec 31, 2015 | 9.89M | -1.10M | -9.98% |
| Dec 31, 2014 | 10.98M | 1.03M | 10.29% |
| Dec 31, 2013 | 9.96M | 403.00K | 4.22% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InnerScope Hearing Technologies | 14.51M |
| Lancer Orthodontics | 6.19M |
| SheerVision | 2.84M |
| American Scientific Resources | 1.05M |
| Paradigm Medical Industries | 757.00K |
| Wearable Health Solutions | 600.26K |
| Medical International Technology | 397.69K |
| Hear AtLast Holdings | 93.20K |